Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design - Woudstra, Pier; Grundeken, Maik J.; Kraak, Robin P.; Hassell, Mariëlla E.C.J.; Arkenbout, E. Karin; Baan, Jan; Vis, Marije M.; Koch, Karel T.; Tijssen, Jan G.P.; Piek, Jan J.; de Winter, Robbert J.; Henriques, José P.S.; et al. (The American heart journal, 2014)
Keywords: Aged; Angioplasty; Cardiovascular; Coated Materials, Biocompatible; Coronary Artery Disease - surgery; Coronary Restenosis - prevention & control; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Heart attacks; Humans; Informed consent; Male; Middle Aged; Percutaneous Coronary Intervention - methods; Prospective Studies; Single-Blind Method; Sirolimus - analogs & derivatives; Sirolimus - pharmacology; Stents; Treatment Outcome; Netherlands